Vaccinum influenzae pandemicae (H5N1) (virion integrum, inactivatum, ex cellulis)

Medicinal product name Pandemic influenza vaccine H5N1 Baxter
Pharmaceutical form Suspension for injection
Strength 7.5 μg/0.5 ml 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code J07BB01 Vaccines

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(7,5 µg/0,5 ml)
Glass pre-filled syringe without needle    EU/1/09/571/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/09/571/002
Date of authorisation Oct 16, 2009
Marketing authorisation holder, country Ology Bioservices Ireland LTD, Ireland